Inno-Gene SA
WSE:IGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Irm Energy Ltd
NSE:IRMENERGY
|
IN |
|
Eltek Ltd
NASDAQ:ELTK
|
IL |
Inno-Gene SA
Operating Income
Inno-Gene SA
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Inno-Gene SA
WSE:IGN
|
Operating Income
-zł2.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
N
|
Nanogroup SA
WSE:NNG
|
Operating Income
-zł10.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Operating Income
-zł2.1m
|
CAGR 3-Years
-93%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Operating Income
-zł97.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
S
|
Selvita SA
WSE:SLV
|
Operating Income
zł10.7m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Inno-Gene SA
Glance View
Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
See Also
What is Inno-Gene SA's Operating Income?
Operating Income
-2.6m
PLN
Based on the financial report for Jun 30, 2024, Inno-Gene SA's Operating Income amounts to -2.6m PLN.
What is Inno-Gene SA's Operating Income growth rate?
Operating Income CAGR 10Y
-12%
Over the last year, the Operating Income growth was -9%.
